ROGER KENJI LONG M.D.
Prescription History 1285641449
Pediatrics - Pediatric Endocrinology in San Francisco, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ROGER KENJI LONG M.D., an active Pediatric Endocrinology specialist practicing in San Francisco, CA. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 256 documented patient claims. Among these therapy options, the most frequently utilized medication is Alendronate Sodium, which accounts for 146 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Alendronate Sodium | 146 | $10.55▼ below CA avg | ▲ More than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2023, this provider wrote 146 Medicare prescriptions for Alendronate Sodium, about 2.5 times the volume of the typical California prescriber of this medication (58). Medicare paid an average of $10.55 per fill, versus $12.46 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 288.1 30-Day Fills standardized to 30-day supplies 8,503 Days of Medication total across all patients in 2023 | |||
| TymlosAbaloparatide | 41 | $2,724.46 | ▲ More than typical |
About Tymlos: Abaloparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication should not be used for children or young adults whose bones are still growing. In 2023, this provider wrote 41 Medicare prescriptions for Tymlos, about 1.6 times the volume of the typical California prescriber of this medication (25). Medicare paid an average of $2,724.46 per fill, versus $2,660.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41 30-Day Fills standardized to 30-day supplies 1,230 Days of Medication total across all patients in 2023 | |||
| ForteoTeriparatide | 22 | $4,318.39 | ≈ Typical |
About Forteo: Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing. A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2023, this provider wrote 22 Medicare prescriptions for Forteo, about 85% of the volume of the typical California prescriber of this medication (26). Medicare paid an average of $4,318.39 per fill, versus $3,917.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 640 Days of Medication total across all patients in 2023 | |||
| Teriparatide | 22 | $2,702.64▼ below CA avg | ≈ Typical |
About Teriparatide: Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing. A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2023, this provider wrote 22 Medicare prescriptions for Teriparatide, about 1.2 times the volume of the typical California prescriber of this medication (18). Medicare paid an average of $2,702.64 per fill, versus $2,762.19 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 22 30-Day Fills standardized to 30-day supplies 641 Days of Medication total across all patients in 2023 | |||
| CrysvitaBurosumab-Twza | 13 | $26,631.86 | ▼ Less than typical |
In 2023, this provider wrote 13 Medicare prescriptions for Crysvita, about half the volume of the typical California prescriber of this medication (25). Medicare paid an average of $26,631.86 per fill, versus $21,107.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2023 | |||
| Hydrochlorothiazide | 12 | $2.15▼ below CA avg | ▼ Less than typical |
About Hydrochlorothiazide: This medication is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Hydrochlorothiazide belongs to a class of drugs known as diuretics/water pills. It works by causing you to make more urine. This helps your body get rid of extra salt and water. This medication also reduces extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, or kidney disease. This can lessen symptoms such as shortness of breath or swelling in your ankles or feet. A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. In 2023, this provider wrote 12 Medicare prescriptions for Hydrochlorothiazide, about 18% of the volume of the typical California prescriber of this medication (65). Medicare paid an average of $2.15 per fill, versus $6.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for ROGER KENJI LONG M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pediatric Endocrinology prescribing approach at this San Francisco, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
